Stem Cell Banking Market - Top Companies and Manufacturers

  • Report ID: 4776
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Stem Cell Banking Landscape

    • CBR Systems Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Global Cord Blood Corporation
    • Cordlife Group Limited
    • Cordvidadvdfvdsfsdf
    • Cryo-Cell International, Inc.
    • BrainStorm Cell Limited
    • Cryoviva Biotech Pvt. Ltd.
    • Lifecell International Private Limited
    • Smart Cells International Ltd
    • Viacord, LLC

Browse Key Market Insights with Data Illustration:

In the News

  • As a partner stem cell bank, Smart Cells International Ltd collaborates with the charity Leukaemia & Myeloma Research UK (LMRUK). By participating in this agreement, qualified pregnant moms would have the option to freeze their baby's umbilical cord blood stem cells at the time of birth in case they are later required to treat the child or a sibling if they are a good match.

  • The Brazilian Patent Office has approved the patent application titled, "A method of generating cells which secrete Brain Derived Neurotrophic Factor (BDNF), Glial Derived Neurotrophic Factor (GDNF), Hepatocyte Growth Factor (HGF), and Vascular Endothelial Growth Factor (VEGF), wherein said cells do not secrete Nerve Growth Factor," according to Brainstorm Cell Limited a leading provider of adult stem cell therapeutics for neurode (NGF). The approved claims include a process for producing MSC-NTF cells (NurOwn).


Author Credits:  Radhika Pawar


  • Report ID: 4776
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of stem cell banking is assessed at USD 12.99 billion.

The stem cell banking market size was over USD 11.9 billion in 2024 and is poised to reach USD 48.38 billion by the end of 2037, growing at around 11.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of cardiovascular disease, rise in number of people with Diabetes Type I, surge in approval of products by regulatory authorities, and others

North America is expected to have the highest growth through 2037, backed by growing prevalence of chronic disease, along with well-established medical infrastructure.

The major players in the market include CBR Systems Inc., Global Cord Blood Corporation, Cordlife Group Limited, Cordvidadvdfvdsfsdf, Cryo-Cell International, Inc., BrainStorm Cell Limited, Cryoviva Biotech Pvt. Ltd., Lifecell International Private Limited, Smart Cells International Ltd, Viacord, LLC.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample